Global CMO & CDMO 麻豆原创 Insights, Forecast to 2030

Publication ID:

PB512248628

Publication Date:

December 21, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
麻豆原创 Analysis and Insights: Global CMO & CDMO 麻豆原创
The global CMO & CDMO market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for CMO & CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of CMO & CDMO include Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun and Piramal, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
CMO & CDMO is widely used in various fields, such as Pharmaceutical Industry, Biotechnology and Other,, etc. Pharmaceutical Industry provides greatest supports to the CMO & CDMO industry development. In 2023, global % revenue of CMO & CDMO went into Pharmaceutical Industry filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for CMO & CDMO market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of CMO & CDMO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CMO & CDMO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CMO & CDMO revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CMO & CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CMO & CDMO revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried
Segment by Type
Development
API production
Formulation
Segment by Application
Pharmaceutical Industry
Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CMO & CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO & CDMO companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CMO & CDMO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global CMO & CDMO 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Development
1.2.3 API production
1.2.4 Formulation
1.3 麻豆原创 by Application
1.3.1 Global CMO & CDMO 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO & CDMO 麻豆原创 Perspective (2019-2030)
2.2 Global CMO & CDMO Growth Trends by Region
2.2.1 CMO & CDMO 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 CMO & CDMO Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 CMO & CDMO Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 CMO & CDMO 麻豆原创 Dynamics
2.3.1 CMO & CDMO Industry Trends
2.3.2 CMO & CDMO 麻豆原创 Drivers
2.3.3 CMO & CDMO 麻豆原创 Challenges
2.3.4 CMO & CDMO 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CMO & CDMO by Players
3.1.1 Global CMO & CDMO Revenue by Players (2019-2024)
3.1.2 Global CMO & CDMO Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global CMO & CDMO 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CMO & CDMO, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global CMO & CDMO 麻豆原创 Concentration Ratio
3.4.1 Global CMO & CDMO 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO & CDMO Revenue in 2023
3.5 Global Key Players of CMO & CDMO Head office and Area Served
3.6 Global Key Players of CMO & CDMO, Product and Application
3.7 Global Key Players of CMO & CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO & CDMO Breakdown Data by Type
4.1 Global CMO & CDMO Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global CMO & CDMO Forecasted 麻豆原创 Size by Type (2025-2030)
5 CMO & CDMO Breakdown Data by Application
5.1 Global CMO & CDMO Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global CMO & CDMO Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America CMO & CDMO 麻豆原创 Size (2019-2030)
6.2 North America CMO & CDMO 麻豆原创 Size by Type
6.2.1 North America CMO & CDMO 麻豆原创 Size by Type (2019-2024)
6.2.2 North America CMO & CDMO 麻豆原创 Size by Type (2025-2030)
6.2.3 North America CMO & CDMO 麻豆原创 Share by Type (2019-2030)
6.3 North America CMO & CDMO 麻豆原创 Size by Application
6.3.1 North America CMO & CDMO 麻豆原创 Size by Application (2019-2024)
6.3.2 North America CMO & CDMO 麻豆原创 Size by Application (2025-2030)
6.3.3 North America CMO & CDMO 麻豆原创 Share by Application (2019-2030)
6.4 North America CMO & CDMO 麻豆原创 Size by Country
6.4.1 North America CMO & CDMO 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America CMO & CDMO 麻豆原创 Size by Country (2019-2024)
6.4.3 North America CMO & CDMO 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe CMO & CDMO 麻豆原创 Size (2019-2030)
7.2 Europe CMO & CDMO 麻豆原创 Size by Type
7.2.1 Europe CMO & CDMO 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe CMO & CDMO 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe CMO & CDMO 麻豆原创 Share by Type (2019-2030)
7.3 Europe CMO & CDMO 麻豆原创 Size by Application
7.3.1 Europe CMO & CDMO 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe CMO & CDMO 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe CMO & CDMO 麻豆原创 Share by Application (2019-2030)
7.4 Europe CMO & CDMO 麻豆原创 Size by Country
7.4.1 Europe CMO & CDMO 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe CMO & CDMO 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe CMO & CDMO 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CMO & CDMO 麻豆原创 Size (2019-2030)
8.2 China CMO & CDMO 麻豆原创 Size by Type
8.2.1 China CMO & CDMO 麻豆原创 Size by Type (2019-2024)
8.2.2 China CMO & CDMO 麻豆原创 Size by Type (2025-2030)
8.2.3 China CMO & CDMO 麻豆原创 Share by Type (2019-2030)
8.3 China CMO & CDMO 麻豆原创 Size by Application
8.3.1 China CMO & CDMO 麻豆原创 Size by Application (2019-2024)
8.3.2 China CMO & CDMO 麻豆原创 Size by Application (2025-2030)
8.3.3 China CMO & CDMO 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia CMO & CDMO 麻豆原创 Size (2019-2030)
9.2 Asia CMO & CDMO 麻豆原创 Size by Type
9.2.1 Asia CMO & CDMO 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia CMO & CDMO 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia CMO & CDMO 麻豆原创 Share by Type (2019-2030)
9.3 Asia CMO & CDMO 麻豆原创 Size by Application
9.3.1 Asia CMO & CDMO 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia CMO & CDMO 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia CMO & CDMO 麻豆原创 Share by Application (2019-2030)
9.4 Asia CMO & CDMO 麻豆原创 Size by Region
9.4.1 Asia CMO & CDMO 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia CMO & CDMO 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia CMO & CDMO 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America CMO & CDMO 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Recipharm
11.1.1 Recipharm Company Details
11.1.2 Recipharm Business Overview
11.1.3 Recipharm CMO & CDMO Introduction
11.1.4 Recipharm Revenue in CMO & CDMO Business (2019-2024)
11.1.5 Recipharm Recent Developments
11.2 AMRI3
11.2.1 AMRI3 Company Details
11.2.2 AMRI3 Business Overview
11.2.3 AMRI3 CMO & CDMO Introduction
11.2.4 AMRI3 Revenue in CMO & CDMO Business (2019-2024)
11.2.5 AMRI3 Recent Developments
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon CMO & CDMO Introduction
11.3.4 Patheon Revenue in CMO & CDMO Business (2019-2024)
11.3.5 Patheon Recent Developments
11.4 Aenova
11.4.1 Aenova Company Details
11.4.2 Aenova Business Overview
11.4.3 Aenova CMO & CDMO Introduction
11.4.4 Aenova Revenue in CMO & CDMO Business (2019-2024)
11.4.5 Aenova Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent CMO & CDMO Introduction
11.5.4 Catalent Revenue in CMO & CDMO Business (2019-2024)
11.5.5 Catalent Recent Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup CMO & CDMO Introduction
11.6.4 Amatsigroup Revenue in CMO & CDMO Business (2019-2024)
11.6.5 Amatsigroup Recent Developments
11.7 WuXi PharmaTech
11.7.1 WuXi PharmaTech Company Details
11.7.2 WuXi PharmaTech Business Overview
11.7.3 WuXi PharmaTech CMO & CDMO Introduction
11.7.4 WuXi PharmaTech Revenue in CMO & CDMO Business (2019-2024)
11.7.5 WuXi PharmaTech Recent Developments
11.8 Strides Shasun
11.8.1 Strides Shasun Company Details
11.8.2 Strides Shasun Business Overview
11.8.3 Strides Shasun CMO & CDMO Introduction
11.8.4 Strides Shasun Revenue in CMO & CDMO Business (2019-2024)
11.8.5 Strides Shasun Recent Developments
11.9 Piramal
11.9.1 Piramal Company Details
11.9.2 Piramal Business Overview
11.9.3 Piramal CMO & CDMO Introduction
11.9.4 Piramal Revenue in CMO & CDMO Business (2019-2024)
11.9.5 Piramal Recent Developments
11.10 Siegfried
11.10.1 Siegfried Company Details
11.10.2 Siegfried Business Overview
11.10.3 Siegfried CMO & CDMO Introduction
11.10.4 Siegfried Revenue in CMO & CDMO Business (2019-2024)
11.10.5 Siegfried Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.